Clinical Trial Update: Armodafinil (CEP-10953) in Treatment of Excessive Sleepiness Associated With Obstructive Sleep Apnea/Hypopnea (OSA/H) Syndrome [Phase 3]

View source ↗

Summary

Phase 3 trial update for armodafinil in excessive sleepiness associated with obstructive sleep apnea-hypopnea syndrome, with results posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obstructive Sleep Apnea-hypopnea Syndrome

Drugs mentioned

• Armodafinil (armodafinil)

Snippet

Sponsor: Cephalon | Conditions: Obstructive Sleep Apnea, Sleep Hypopnea | Phase 3 | Status: COMPLETED | Results posted: 2010-02-03